7Baggers

Cidara Therapeutics, Inc
(NASDAQ:CDTX) 

CDTX stock logo

Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of novel long-acting anti-infectives for the treatment and prevention of diseases in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the...

Founded: 2012
Full Time Employees: 68
Sector: Healthcare
Industry: Biotechnology
Pharmaceuticals
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 
                                        
      revenues:
    		                                    
      collaboration revenue
    		     302,000 5,637,000 14,716,000 11,250,000 7,614,000 25,990,000 10,219,000 40,744,000 6,216,000 7,109,000 7,225,000 7,076,000 32,863,000 2,408,000 3,729,000 2,416,000 3,392,000 2,530,000 1,815,000 19,100,000            
      total revenues
    		     302,000 8,463,000 17,583,000 12,718,000 7,614,000 25,990,000 10,219,000 40,744,000 6,216,000 7,109,000 7,225,000 7,076,000 32,863,000 2,408,000 3,729,000 2,416,000 3,392,000 2,530,000 1,815,000 19,100,000            
      yoy
    		NaN% NaN% NaN%  NaN% -96.03% -67.44% 72.06% -68.79% 22.49% 265.59% 41.44% 475.81% -81.09% 195.22% 93.75% 192.88% 868.84% -4.82% 105.45% -87.35%                
      qoq
    		NaN% NaN%   NaN% -96.43% -51.87% 38.25% 67.03% -70.70% 154.33% -74.92% 555.47% -12.56% -1.61% 2.11% -78.47% 1264.74% -35.43% 54.35% -28.77% 34.07% 39.39% -90.50%             
      operating expenses:
    		                                    
      acquired in-process research and development
    		45,000,000     84,883,000                               
      research and development
    		35,529,000 24,817,000 24,600,000 46,874,000 12,429,000 6,657,000 11,593,000 15,352,000 17,330,000 17,135,000 18,715,000 20,058,000 20,041,000 15,255,000 20,166,000 19,013,000 20,505,000 17,720,000 15,849,000 21,129,000 16,258,000 17,634,000 12,996,000 11,490,000 11,499,000 10,743,000 12,669,000 13,046,000 11,278,000 11,619,000 13,199,000 9,159,000 13,191,000 10,243,000 11,310,000 8,729,000 
      general and administrative
    		8,099,000 6,502,000 6,179,000     2,791,000 3,556,000 3,310,000 4,298,000 3,428,000 5,780,000 4,074,000 5,204,000 4,982,000 4,607,000 4,370,000 4,781,000 4,148,000 3,687,000 3,969,000 4,095,000 4,405,000 4,573,000 3,525,000 3,735,000 3,552,000 3,447,000 3,533,000 3,611,000 3,090,000 3,424,000 3,155,000 3,043,000 3,607,000 
      reversal due to settlement of indirect tax liabilities
    		 -3,935,000                                   
      total operating expenses
    		88,628,000 27,384,000 25,269,000 54,182,000 17,394,000 96,286,000 19,154,000 23,657,000 21,273,000 20,445,000 23,013,000 23,486,000 25,821,000 19,329,000 25,370,000 23,995,000 25,112,000 22,090,000 20,630,000 25,277,000 19,945,000 21,603,000 17,091,000 15,895,000 16,072,000 14,268,000 16,404,000 16,598,000 14,725,000 15,152,000 16,810,000 12,249,000 16,615,000 13,398,000 14,353,000 12,336,000 
      income from operations
    		-88,628,000 -27,384,000 -25,269,000 -54,182,000 -17,394,000 -95,984,000 -10,691,000 -6,074,000 -8,555,000 -12,831,000 2,977,000 -13,267,000 14,923,000 -13,113,000 -18,261,000 -16,770,000 -18,036,000 10,773,000 -18,222,000 -21,548,000 -17,529,000 -18,211,000 -14,561,000 -14,080,000 3,028,000 -14,268,000 -16,404,000 -16,598,000 -14,725,000 -15,152,000 -16,810,000 -12,249,000 -16,615,000 -13,398,000 -14,353,000 -12,336,000 
      yoy
    		409.53% -71.47% 136.36% 792.03% 103.32% 648.06% -459.12% -54.22% -157.33% -2.15% -116.30% -20.89% -182.74% -221.72% 0.21% -22.17% 2.89% -159.16% 25.14% 53.04% -678.90% 27.64% -11.24% -15.17% -120.56% -5.83% -2.42% 35.50% -11.38% 13.09% 17.12% -0.71%     
      qoq
    		223.65% 8.37% -53.36% 211.50% -81.88% 797.80% 76.01% -29.00% -33.33% -531.00% -122.44% -188.90% -213.80% -28.19% 8.89% -7.02% -267.42% -159.12% -15.44% 22.93% -3.74% 25.07% 3.42% -564.99% -121.22% -13.02% -1.17% 12.72% -2.82% -9.86% 37.24% -26.28% 24.01% -6.65% 16.35%  
      operating margin %
    		NaN% NaN% NaN% -Infinity% NaN% -31782.78% -126.33% -34.54% -67.27% -168.52% 11.45% -129.83% 36.63% -210.96% -256.87% -232.11% -254.89% 32.78% -756.73% -577.85% -725.54% -536.88% -575.53% -775.76% 15.85% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% 
      other income, net:
    		                                    
      other expense
    		  -110,000                                  
      interest income
    		5,395,000 1,666,000 1,899,000 1,813,000 1,859,000 1,774,000 365,000 527,000 613,000 623,000 232,000 162,000 55,000      -70,000 -86,000 -103,000 -95,000 22,000 57,000 11,000 40,000 113,000 182,000 222,000 164,000 61,000 -8,000 -30,000  -41,000 109,000 
      total other income
    		5,395,000 1,666,000 1,789,000 1,813,000 1,859,000 1,774,000 365,000 527,000 613,000 623,000 232,000 162,000 55,000      -70,000 -86,000 -103,000 -95,000 22,000 57,000 11,000 721,000 -157,000 4,256,000 1,106,000 -1,154,000 61,000 -8,000 -30,000  -41,000 109,000 
      net income from continuing operations
    		-83,233,000 -25,718,000 -23,480,000 -52,369,000 -15,535,000 -94,210,000                               
      income from discontinued operations (including loss on disposal of discontinued operations of zero and 1,799 during the three and nine months ended september 30, 2024, respectively), net of income taxes
    		   100,500 -450,000                                
      net income
    		-83,233,000                       -14,023,000 3,039,000 -13,547,000 -16,561,000 -12,342,000 -13,619,000 -16,306,000 -16,749,000 -12,257,000 -16,645,000 -13,398,000 -14,394,000 -12,227,000 
      yoy
    		                       13.62% -122.31% -16.92% -1.12% 0.69% -18.18% 21.70% 16.36% 0.25%     
      qoq
    		                       -561.43% -122.43% -18.20% 34.18% -9.38% -16.48% -2.64% 36.65% -26.36% 24.23% -6.92% 17.72%  
      net income margin %
    		NaN% NaN% NaN% NaN% NaN% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% -772.62% 15.91% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% 
      basic and diluted net loss per common share from continuing operations
    		-3,100 -1,650 -1,660 -4,210 -2,380 -20,650                               
      basic and diluted net earnings per common share from discontinued operations
    		   -10 -70 660                               
      basic and diluted net loss per common share
    		-3,100 -1,650 -1,660 -4,220 -2,450 -19,990    -140     -270 -280 -370                    
      shares used to compute basic and diluted net earnings per common share
    		26,882,366,000   1,134,266,000 6,530,111,000 4,563,772,000                               
      unrealized loss on available-for-sale investments
    		-107,000                                    
      comprehensive loss
    		-83,340,000                         -13,547,000 -16,561,000 -12,341,000 -13,617,000 -16,291,000 -16,759,000 -12,258,000 -16,641,000 -13,401,000 -14,378,000 -12,240,000 
      income from discontinued operations (including loss on disposal of discontinued operations of 1,799 during the three and six months ended june 30, 2024), net of income taxes
    		     3,001,000                               
      net loss and comprehensive loss
    		 -25,718,000 -23,480,000 -52,307,000 -15,985,000 -91,209,000    -12,357,000     -18,281,000 -16,803,000 -18,083,000                    
      shares used to compute basic and diluted net loss per common share
    		 15,547,403,000 14,177,743,000       90,115,859,000     68,138,116,000 4,051,357,000 49,533,956,000                    
      reversal of indirect tax liabilities
    		  -5,510,000                                  
      loss from discontinued operations, net of income taxes
    		                                    
      basic and diluted net loss per common share from discontinued operations
    		                                    
      selling, general and administrative
    		   3,326,750 4,965,000 4,746,000 5,998,000                              
      net loss from continuing operations before income tax expense
    		   -52,369,000 -15,535,000 -94,210,000                               
      income tax benefit
    		                                    
      income tax expense
    		       -64,000 -230,000 -149,000                           
      product revenue
    		      2,826,000 2,867,000 1,468,000                            
      cost of product revenue
    		      1,563,000 1,136,000 387,000                            
      net income and comprehensive income
    		      -10,326,000 -4,330,000 -8,172,000  3,209,000 -4,105,500 14,978,000 -13,119,000    10,711,000  -12,619,250 -17,632,000                
      allocation of earnings to participating securities
    		          -677,000  -3,081,000     -1,892,000       -444,000            
      net income attributable to common stockholders
    		      -10,326,000 -4,330,000 -8,172,000  2,532,000 -4,105,500 11,897,000 -13,119,000                       
      basic net earnings per common share
    		      -2,280 -50 -90  30 -60 170 -190    180  -327.5 -410                
      diluted net earnings per common share
    		      -2,280 -50 -90  30 -60 170 -190    180  -327.5 -410                
      shares used to compute basic net earnings per common share
    		      4,537,782,000 21,597,611,500 90,287,441,000  78,640,086,000 17,292,716,250 70,217,985,000 69,133,700,000    48,677,008,000  10,171,457,000 43,208,308,000                
      shares used to compute diluted net earnings per common share
    		      4,537,782,000 21,597,611,500 90,287,441,000  101,189,396,000 17,292,716,250 88,592,568,000 69,133,700,000    59,323,220,000  10,171,457,000 43,208,308,000                
      net income before income tax expense
    		       -4,235,250 -7,942,000                            
      other income:
    		                                    
      net loss before income tax expense
    		         -12,208,000                           
      other expense:
    		                                    
      interest expense
    		             -6,000 -20,000 -44,750 -47,000 -62,000                   
      total other expense
    		             -6,000 -20,000 -44,750 -47,000 -62,000                   
      net loss attributable to common shareholders
    		              -18,281,000 -16,803,000 -18,083,000                    
      recognition of beneficial conversion feature
    		                      -2,762,000       -10,329,000       
      net income attributable to common shareholders
    		                 8,819,000 -18,292,000 -21,634,000 -17,632,000 -18,306,000 -17,301,000 -14,023,000 2,595,000 -13,547,000 -16,561,000 -12,342,000 -13,619,000 -26,635,000       
      net income and comprehensive loss
    		                  -18,292,000   -18,306,000 -14,539,000              
      basic and diluted net income per common share
    		                  -390   -450 -460   -490 -600 -410 -490 -1,130       
      shares used to compute basic and diluted net income per common share
    		                  46,967,213,000   40,965,180,000 37,856,338,000   27,786,808,000 27,729,977,000 888,722,000 27,705,472,000 23,592,763,000       
      change in fair value of contingent forward purchase obligations
    		                       102,750  681,000 -270,000 -56,000 888,000 -1,112,000       
      other income
    		                           -1,000 -4,000 -206,000       
      basic earnings per common share
    		                       -270 80            
      diluted earnings per common share
    		                       -270 80            
      shares used to compute basic net income per common share
    		                       6,252,894,000 33,006,280,000            
      shares used to compute diluted net income per common share
    		                       6,252,894,000 38,687,937,000            
      unrealized gain on short-term investments
    		                           1,000 2,000 15,000   4,000 -3,000 16,000 -13,000 
      comprehensive income
    		                       -6,767,250 3,039,000            
      unrealized loss on short-term investments
    		                              -10,000 -1,000     
      other comprehensive loss:
    		                                    
      basic and diluted net income per share
    		                              -0.8 -0.73 -0.99  -0.88 -0.88 
      shares used to compute basic and diluted net income per share
    		                              20,894,353 16,864,211 16,831,960  625,534 13,910,145 
      basic and diluted net loss per share
    		                                 -0.8   
      shares used to compute basic and diluted net loss per share
    		                                 16,795,366   
      other comprehensive income:
    		                                    
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 
                                          
        assets
      		                                    
        current assets:
      		                                    
        cash and cash equivalents
      		293,651,000 510,575,000 168,150,000 189,825,000 127,386,000 164,369,000 29,018,000 35,778,000 48,670,000 50,430,000 47,976,000 32,731,000 53,078,000 24,637,000 36,488,000 59,680,000 36,601,000 48,284,000 42,863,000 35,912,000 45,520,000 54,826,000 64,314,000 50,268,000 73,824,000 44,573,000 57,407,000 74,562,000 83,780,000 88,954,000 52,218,000 54,276,000 78,012,000 82,198,000 85,367,000 24,622,000 
        restricted cash
      		6,337,000 6,338,000 6,339,000 6,352,000          370,000 1,482,000 2,593,000 3,704,000 4,815,000 5,926,000 7,037,000 8,148,000 9,259,000 10,000,000 10,000,000       792,000      
        short-term investments, available-for-sale
      		126,370,000                                    
        accounts receivable
      		1,861,000 1,859,000 1,694,000 1,694,000 1,699,000 2,349,000 7,281,000 16,246,000 2,855,000 5,483,000 25,826,000 5,833,000 5,042,000 4,833,000 8,783,000 5,356,000 3,872,000 3,157,000 11,000 11,175,000          41,000 288,000 321,000 215,000    
        prepaid expenses and other current assets
      		14,602,000 13,019,000 12,665,000 12,866,000 27,686,000 1,870,000 3,266,000 2,734,000 3,712,000 4,373,000 5,686,000 6,530,000 5,779,000 6,706,000 5,254,000 4,069,000 3,099,000 4,820,000 2,501,000 3,067,000     3,664,000 3,173,000 2,869,000 2,567,000 3,687,000 2,753,000 1,719,000 1,730,000 1,576,000 1,195,000 779,000 1,270,000 
        total current assets
      		442,821,000 531,791,000 188,848,000 210,737,000 156,771,000 168,588,000 46,834,000 60,855,000 57,704,000 62,240,000 79,488,000 45,094,000 63,899,000 36,546,000 52,007,000 71,698,000 47,276,000 61,076,000 51,301,000 57,191,000 60,187,000 70,039,000 80,621,000 65,814,000 77,488,000 47,746,000 60,276,000 77,129,000 91,961,000 105,994,000 68,990,000 66,203,000 79,803,000 91,281,000 105,398,000 80,579,000 
        property and equipment
      		293,000 321,000 348,000 521,000 561,000 602,000 534,000 557,000 580,000 297,000 270,000 222,000 173,000 201,000 239,000 256,000 216,000 261,000 285,000 342,000 396,000 472,000 394,000 429,000 496,000 577,000 635,000 712,000 786,000 824,000 936,000 1,043,000 1,165,000 1,292,000 1,374,000 1,463,000 
        finance lease right-of-use asset
      		   703,000 722,000 742,000 762,000 782,000                             
        operating lease right-of-use asset
      		1,795,000 2,120,000 2,435,000 2,739,000 3,035,000 3,321,000 3,599,000 3,788,000 4,131,000 4,388,000 917,000 1,205,000 1,491,000 1,764,000 2,030,000 2,287,000 2,540,000 446,000 663,000 868,000 1,063,000 1,257,000 1,447,000 1,632,000 1,810,000 1,983,000 2,131,000          
        long-term investments, available-for-sale
      		50,159,000                                    
        other assets
      		23,582,000 95,000 96,000 96,000 1,242,000 104,000 987,000 1,048,000 1,053,000 1,061,000 1,061,000 1,072,000 1,295,000 1,013,000 1,019,000 1,084,000 1,174,000 1,961,000 1,961,000 2,023,000 2,023,000 1,635,000 1,635,000 1,101,000 1,902,000 1,446,000 1,271,000 1,271,000 62,000 190,000 321,000 190,000 190,000 190,000 190,000 190,000 
        total assets
      		518,650,000 534,327,000 191,727,000 214,796,000 162,331,000 173,357,000 52,716,000 67,030,000 63,468,000 67,986,000 81,736,000 47,593,000 66,858,000 39,524,000 55,295,000 75,325,000 51,206,000 63,744,000 54,210,000 60,424,000 63,669,000 73,403,000 84,097,000 68,976,000 81,696,000 51,752,000 64,313,000 79,112,000 92,809,000 107,008,000 70,247,000 67,436,000 81,158,000 92,763,000 106,962,000 82,232,000 
        liabilities and stockholders’ equity
      		                                    
        current liabilities:
      		                                    
        accounts payable
      		4,351,000 2,206,000 4,897,000 3,608,000 2,967,000 2,288,000 5,055,000 3,772,000 3,661,000 1,899,000 3,980,000 1,447,000 4,244,000 3,091,000 2,861,000 1,301,000 3,242,000 2,587,000 3,215,000 4,568,000 2,024,000 2,933,000 2,560,000 1,887,000 2,679,000 1,787,000 1,713,000 2,846,000 2,439,000 2,611,000 2,999,000 1,777,000 4,817,000 1,912,000 2,909,000 2,957,000 
        accrued liabilities
      		71,349,000 11,054,000 19,833,000 13,348,000 8,569,000 6,225,000 8,241,000 14,177,000 11,772,000 10,022,000 9,078,000 7,672,000 8,162,000 8,567,000 9,234,000 10,198,000 8,525,000 8,101,000 9,047,000 7,959,000 6,167,000 4,426,000 3,741,000 4,068,000 4,320,000 3,585,000 3,786,000 3,883,000 3,385,000 4,790,000 4,516,000 3,186,000 3,461,000 3,440,000 3,338,000 3,033,000 
        accrued indirect tax liabilities
      		15,073,000 14,935,000 20,727,000 26,045,000 26,289,000 26,083,000 20,618,000 18,040,000                             
        accrued compensation and benefits
      		3,506,000 2,626,000 1,915,000 4,911,000 4,933,000 3,514,000 5,723,000 5,034,000 4,457,000 3,582,000 5,843,000 4,922,000 4,117,000 3,464,000 3,079,000 4,859,000 3,964,000 3,446,000 5,661,000 4,210,000 3,550,000 2,900,000 2,235,000 3,658,000 2,932,000 2,526,000 2,049,000 2,824,000 2,585,000 2,143,000 1,921,000 1,987,000 1,713,000 1,534,000 2,662,000 2,242,000 
        current portion of finance lease liability
      		   264,000 259,000 254,000 249,000 218,000                             
        current portion of operating lease liability
      		1,560,000 1,497,000 1,437,000 1,378,000 1,322,000 1,268,000 1,215,000 1,082,000                             
        total current liabilities
      		95,839,000 32,318,000 48,809,000 49,554,000 44,339,000 39,643,000 65,425,000 67,418,000 35,620,000 31,420,000 35,663,000 29,972,000 33,049,000 31,455,000 32,105,000 34,017,000 33,490,000 33,887,000 39,966,000 38,564,000 33,871,000 31,567,000 29,629,000 30,199,000 31,579,000 18,608,000 18,897,000 19,892,000 13,562,000 14,918,000 11,519,000 8,617,000 10,658,000 6,886,000 8,909,000 8,232,000 
        long-term finance lease liability
      		   310,000 378,000 445,000 510,000 575,000                             
        long-term operating lease liability
      		424,000 836,000 1,236,000 1,624,000 1,984,000 2,333,000 2,673,000 3,002,000                             
        total liabilities
      		96,263,000 33,154,000 50,045,000 51,488,000 46,701,000 42,421,000 70,496,000 75,240,000 55,430,000 52,572,000 54,899,000 50,497,000 57,791,000 47,485,000 50,338,000 53,752,000 52,364,000 47,955,000 52,318,000 49,709,000 34,116,000 32,051,000 30,345,000 31,141,000 32,734,000 19,970,000 20,451,000 19,973,000 22,877,000 24,870,000 19,328,000 16,863,000 19,894,000 16,774,000 18,783,000 8,317,000 
        commitments and contingencies
      		                                    
        stockholders’ equity:
      		                                    
        preferred stock, 0.0001 par value...
      		                                    
        series a convertible voting preferred stock, 0.0001 par value...
      		                                    
        series x convertible preferred stock, 0.0001 par value...
      		                                    
        common stock, 0.0001 par value...
      		3,000 2,000 1,000 1,000 1,000 1,000 1,000 9,000 9,000 9,000 9,000 7,000 7,000 7,000 7,000 7,000 5,000 5,000 5,000 4,000 4,000 4,000 4,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 2,000 2,000 2,000 2,000 2,000 1,000 
        additional paid-in capital
      		1,166,180,000 1,161,627,000 776,419,000 774,565,000 674,580,000 673,901,000 433,976,000 433,212,000 432,315,000 431,519,000 430,585,000 404,055,000 402,649,000 400,599,000 400,398,000 398,733,000 359,201,000 358,065,000 354,879,000 345,411,000 342,615,000 336,782,000 330,876,000 297,659,000 294,763,000 280,622,000 279,155,000 277,871,000 276,323,000 274,912,000 217,073,000 186,534,000 184,967,000 183,051,000 181,840,000 153,199,000 
        accumulated other comprehensive loss
      		-107,000                            -1,000 -3,000 -18,000 -1,000  -4,000 -1,000 -17,000 
        accumulated deficit
      		-743,689,000 -660,456,000 -634,738,000 -611,258,000 -558,951,000 -542,966,000 -451,757,000 -441,431,000 -424,286,000 -416,114,000 -403,757,000 -406,966,000 -393,589,000 -408,567,000 -395,448,000 -377,167,000 -360,364,000 -342,281,000 -352,992,000 -334,700,000 -313,066,000 -295,434,000 -277,128,000 -259,827,000 -245,804,000 -248,843,000 -235,296,000 -218,735,000 -206,393,000 -192,774,000 -166,138,000 -135,962,000 -123,705,000 -107,060,000 -93,662,000 -79,268,000 
        total stockholders’ equity
      		422,387,000 501,173,000 141,682,000 163,308,000 115,630,000 130,936,000   8,038,000 15,414,000 26,837,000 -2,904,000                         
        total liabilities and stockholders’ equity
      		518,650,000 534,327,000 191,727,000 214,796,000 162,331,000 173,357,000   63,468,000 67,986,000 81,736,000 47,593,000                         
        current assets from discontinued operations
      		                                    
        noncurrent assets from discontinued operations
      		                                    
        liabilities and stockholders’ deficit
      		                                    
        current contract liabilities
      		      24,324,000 25,095,000 14,679,000                            
        current liabilities from discontinued operations
      		     11,000                               
        noncurrent liabilities from discontinued operations
      		                                    
        stockholders’ equity
      		                                    
        series a convertible voting preferred stock, 0.0001 par value (liquidation preference 720,000 at june 30, 2024); 240,000 shares authorized at june 30, 2024; 240,000 shares issued and outstanding at june 30, 2024; no shares issued and outstanding at december 31, 2023
      		                                    
        inventory
      		      7,269,000 6,097,000 2,467,000 1,954,000                           
        long-term contract liabilities
      		      1,888,000 4,245,000 16,504,000                            
        stockholders’ deficit:
      		                                    
        total stockholders’ deficit
      		      -17,780,000 -8,210,000                             
        total liabilities and stockholders’ deficit
      		      52,716,000 67,030,000                             
        current portion of lease liability
      		        1,051,000 942,000  1,317,000 1,277,000 1,233,000 1,190,000 1,148,000 1,029,000 484,000 716,000 939,000 910,000 878,000 848,000 818,000 790,000 762,000 730,000          
        long-term lease liability
      		        3,306,000 3,601,000                           
        current deferred revenue
      		         14,975,000 15,761,000 14,614,000 15,249,000 14,730,000 14,260,000 13,920,000 13,030,000 14,461,000 15,411,000 13,865,000                 
        long-term deferred revenue
      		         17,551,000 19,236,000 20,525,000 24,398,000 15,351,000 17,229,000 18,413,000 17,254,000 14,068,000 12,352,000 11,145,000                 
        lease liability
      		          1,001,000  344,000 679,000 1,004,000 1,322,000 1,620,000    245,000 484,000 716,000 942,000 1,155,000 1,362,000 1,554,000          
        current portion of term loan
      		             370,000 1,481,000 2,591,000 3,700,000 4,808,000 5,916,000 7,023,000 8,129,000 9,234,000 9,966,000 9,965,000 9,958,000 9,948,000 9,938,000 9,928,000 667,000  2,083,000 1,667,000 667,000    
        liabilities and stockholders' equity
      		                                    
        stockholders' equity:
      		                                    
        total stockholders' equity
      		            9,067,000 -7,961,000 4,957,000 21,573,000 -1,158,000 15,789,000 1,892,000 10,715,000 29,553,000 41,352,000 53,752,000 37,835,000 48,962,000 31,782,000 43,862,000 59,139,000 69,932,000 82,138,000 50,919,000 50,573,000 61,264,000 75,989,000 88,179,000 73,915,000 
        total liabilities and stockholders' equity
      		            66,858,000 39,524,000 55,295,000 75,325,000 51,206,000 63,744,000 54,210,000 60,424,000 63,669,000 73,403,000 84,097,000 68,976,000 81,696,000 51,752,000 64,313,000 79,112,000 92,809,000 107,008,000 70,247,000 67,436,000 81,158,000 92,763,000 106,962,000 82,232,000 
        stockholders' equity
      		                                    
        accounts receivable, prepaid expenses and other current assets
      		                    6,519,000 5,954,000 6,307,000 5,546,000             
        deferred revenue
      		                    13,091,000 11,196,000 10,279,000 9,803,000 10,900,000            
        contingent forward purchase obligation
      		                           411,000         
        other long-term liabilities
      		                           81,000 62,000 42,000  61,000 71,000 75,000 80,000 85,000 
        contingent forward purchase obligations
      		                          681,000  4,486,000 5,374,000       
        short-term investments
      		                            4,494,000 14,246,000 13,973,000 9,876,000  7,888,000 19,252,000 54,687,000 
        term loan, less debt issuance costs
      		                            9,253,000 9,910,000 7,809,000 8,185,000 9,165,000 9,813,000 9,794,000  
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-09-30 2017-06-30 2017-03-31 2016-12-31 
                                         
          operating activities:
        		                                 
          net income
        		      -10,326,000    3,209,000        -18,292,000 -21,634,000 -17,632,000 -18,306,000 -14,539,000 -14,023,000 3,039,000 -13,547,000 -16,561,000 -12,342,000 -13,619,000 -12,257,000   -14,394,000 
          adjustments to reconcile net income to net cash from operating activities:
        		                                 
          stock-based compensation expense
        		3,171,000                                 
          non-cash operating lease expense
        		326,000 314,000 305,000 295,000 287,000 278,000 188,000 237,000 257,000                         
          loss on assignment of finance lease
        		0 0 158,000                               
          depreciation and amortization
        		28,000 27,000 36,000 40,000 41,000 37,000 36,000 33,000 22,000 25,000 32,000 29,000 37,000 38,000 39,000 37,000 45,000 50,000 57,000 67,000 76,000 72,000 71,000 77,000 81,000 84,000 86,000 111,000 137,000 144,000 186,000 198,000 185,000 
          amortization of finance lease right-of-use asset
        		0 0 13,000 19,000 20,000 20,000 20,000                           
          non-cash interest expense
        		0 0 7,000 12,000 14,000 14,000 16,000     0 0 0 1,000 2,000 2,000 5,000 3,000 3,000 5,000 7,000 1,000 6,000 7,000 8,000 7,000   20,000 19,000 19,000  
          gain on disposal of property and equipment
        		0 0 -48,000                               
          accretion of discounts, net of amortization of premiums, on available-for-sale investments
        		                                 
          reversal due to settlement of indirect tax liabilities
        		0                                 
          loss on disposal of discontinued operations
        		   0 0                             
          amortization of costs to obtain a contract with a customer
        		   0 0 168,000 16,000 24,000 13,000 -435,000 475,000                       
          changes in assets and liabilities:
        		                                 
          accounts receivable
        		-2,000   5,000 650,000 4,655,000 8,965,000 -13,391,000 2,628,000 20,343,000 -19,993,000 -791,000 -210,000 3,951,000 -3,427,000 -1,484,000 -715,000 -3,146,000 11,164,000          40,000 -122,000    
          inventory
        		   0 0 7,269,000 -1,172,000 -3,630,000 -513,000                         
          prepaid expenses, other current assets, and other assets
        		-24,971,000 -392,000 186,000 15,981,000 -26,955,000 396,000 -273,000 959,000 656,000 1,248,000 872,000 -778,000 905,000 -1,447,000 -1,120,000  2,506,000 -2,254,000 461,000               
          accounts payable and accrued liabilities
        		63,564,000 -12,594,000 7,775,000 5,421,000 3,163,000 -4,734,000 -4,851,000 2,682,000 3,334,000 -246,000 3,116,000 -1,334,000 -554,000 -1,140,000 657,000 -282,000 1,027,000 -1,585,000 -253,000 4,326,000 884,000 1,002,000 379,000 -1,054,000 1,627,000 -126,000 -1,231,000 908,000 606,000 -3,321,000 2,935,000 -799,000 306,000 
          accrued indirect tax liabilities
        		138,000 -1,857,000 192,000 -244,000 206,000 5,465,000 2,578,000                           
          accrued compensation and benefits
        		879,000 744,000 -2,996,000 10,000 1,419,000 -2,154,000 689,000 637,000 875,000 -2,198,000 921,000 873,000 654,000 629,000 -1,953,000 1,079,000 518,000 -1,963,000 1,451,000 921,000 650,000 896,000 -1,422,000 925,000 406,000         
          contract liabilities
        		   0 -11,000 -26,201,000 -3,128,000 -1,843,000                          
          operating lease liabilities
        		-349,000 -340,000 -329,000 -304,000 -295,000 -286,000 -197,000     -303,000 -291,000 -283,000 -276,000                   
          net cash from operating activities
        		-40,615,000 -40,961,000 -21,950,000 -29,414,000 -36,695,000 -103,780,000 -6,644,000 -12,722,000 -1,634,000 2,822,000 -10,898,000 -21,002,000 27,973,000 -11,836,000 -23,608,000 -14,907,000 -11,972,000 3,440,000 -1,793,000 -11,128,000 -14,083,000 -14,072,000 -15,128,000 -15,197,000 16,619,000 -12,808,000 -17,146,000 -13,666,000 -12,784,000 -13,868,000 -12,032,000 -14,518,000 -11,726,000 
          capital expenditures
        		0 0  0 -106,000 0  -345,000 -126,000 -107,000 -39,000 -9,000 -9,000 -16,000 -68,000 0 -12,000 -17,000 -12,000 0 -54,000 -96,000 -36,000 0 0 -26,000 -9,000 -40,000 -82,000 9,000 -59,000 -116,000 -114,000 
          free cash flows
        		-40,615,000 -40,961,000  -29,414,000 -36,801,000 -103,780,000  -13,067,000 -1,760,000 2,715,000 -10,937,000 -21,011,000 27,964,000 -11,852,000 -23,676,000 -14,907,000 -11,984,000 3,423,000 -1,805,000 -11,128,000 -14,137,000 -14,168,000 -15,164,000 -15,197,000 16,619,000 -12,834,000 -17,155,000 -13,706,000 -12,866,000 -13,859,000 -12,091,000 -14,634,000 -11,840,000 
          investing activities:
        		                                 
          purchases of available-for-sale investments
        		                                 
          proceeds from sales of property and equipment
        		0 0 185,000                               
          purchases of property and equipment
        		   0 -106,000 0 -23,000 -178,000 -126,000 -107,000 -94,000 -9,000 -9,000 -16,000 -84,000 0 -12,000 -17,000 -12,000 0 -54,000 -96,000 -36,000 0 0 -26,000 -9,000 -40,000 -82,000 9,000 -59,000 -116,000 -114,000 
          net cash from investing activities
        		-176,470,000 0 185,000 0 -106,000 0 -23,000 -178,000 -126,000 -107,000 -94,000 -9,000 -9,000 -16,000 -84,000 0 -12,000 -17,000 -12,000 0 -54,000 -96,000 -36,000 0 0 -26,000 -9,000 4,460,000 9,688,000 -9,871,000 7,841,000 11,284,000 35,386,000 
          financing activities:
        		                                 
          proceeds from underwritten public offering, net of issuance costs
        		-1,215,000       0 0 -337,000 17,593,000                       
          proceeds from at-the-market offering of common stock, net of issuance costs
        		-5,000                                 
          proceeds from exercise of stock options
        		1,517,000 997,000 127,000     7,000 0 0 14,000     0 0 5,000 1,000 0 9,000 0 5,000     0 165,000 3,000 5,000 144,000 455,000 
          proceeds from private placement, net of issuance costs
        		    -107,000                             
          payment of finance lease liabilities
        		0 0 -50,000 -76,000 -75,000 -75,000 -50,000                           
          payment for shares withheld to fund payroll taxes
        		   0 0 0 -39,000                           
          net cash from financing activities
        		160,000 383,385,000 77,000 98,205,000 -182,000 239,131,000 -93,000 8,000 0 -261,000 26,237,000 664,000 107,000 -1,111,000 -611,000 36,875,000 -810,000 887,000 7,645,000 409,000 3,720,000 3,939,000 29,210,000 1,641,000    -12,000 -2,078,000 3,000 5,000 65,000 37,085,000 
          net increase in cash, cash equivalents and restricted cash
        		-216,925,000                                 
          cash, cash equivalents and restricted cash at beginning of period
        		0 0 196,177,000                               
          cash, cash equivalents and restricted cash at end of period
        		-216,925,000 342,424,000 174,489,000                               
          supplemental disclosure of cash flows:
        		                                 
          income taxes paid
        		   0 0   146,000 63,000                         
          non-cash financing activities:
        		                                 
          proceeds from exercise of stock options included in prepaid expenses, other current assets, and other assets
        		-149,000                                 
          purchase of shares pursuant to employee stock purchase plan
        		0   32,000 0   59,000 0   71,000 0   185,000 0       201,000 0     0   268,000 
          net loss
        		 -25,718,000 -23,480,000 -52,307,000 -15,985,000   -5,611,000 -8,172,000   -13,377,000 14,978,000 -13,119,000 -18,281,000 -16,803,000 -18,083,000               -13,398,000  
          adjustments to reconcile net loss to net cash from operating activities:
        		                                 
          deferred financing costs
        		                                 
          non-cash investing activities:
        		                                 
          purchases of property and equipment, included in accounts payable and accrued liabilities
        		       -167,000   55,000                       
          issuance costs incurred but not yet paid, included in accounts payable and accrued liabilities
        		     -70,000 105,000    337,000                       
          deferred financing costs incurred but not yet paid
        		                                 
          stock-based compensation
        		  1,741,000 1,658,000 751,000 703,000 795,000 830,000 796,000 795,000 640,000 673,000 843,000 678,000 1,338,000 1,363,000 901,000 871,000 879,000 847,000 1,002,000 995,000 1,246,000 1,023,000 1,509,000 1,257,000 1,284,000 1,364,000 1,285,000 1,554,000 1,601,000 1,051,000 1,090,000 
          reversal of indirect tax liabilities
        		  -5,510,000                               
          issuance costs for private placement
        		      -4,000                           
          net decrease in cash, cash equivalents and restricted cash
        		  -21,688,000                               
          proceeds from private placements, net of issuance costs
        		                                 
          proceeds from public offering of common stock, net of issuance costs
        		       1,000 0 76,000 8,630,000 664,000 1,198,000 0 500,000 1,434,000 301,000 1,993,000 8,755,000               
          cash, cash equivalents and restricted cash at beginning of year
        		                                 
          cash, cash equivalents and restricted cash at end of year
        		                                 
          finance lease right-of-use asset obtained in exchange for lease liability
        		                                 
          operating lease right-of-use asset obtained in exchange for lease liability
        		                                 
          net increase in cash and cash equivalents
        		    -36,983,000 135,351,000 -6,760,000 -12,892,000 -1,760,000 2,454,000 15,245,000              29,251,000   -9,218,000     60,745,000 
          cash and cash equivalents at beginning of period
        		    0 0 35,778,000  0 0 32,731,000              0    0 0 0 85,367,000  
          cash and cash equivalents at end of period
        		    -36,983,000 135,351,000 29,018,000  -1,760,000 2,454,000 47,976,000              29,251,000    -5,174,000 -23,736,000 -4,186,000 82,198,000  
          right-of-use asset obtained in exchange for lease liability
        		        0       0         0 0 2,295,000       
          issuance costs for underwritten public offering
        		           0                      
          principal repayments of term loan
        		           0 -371,000 -1,111,000 -1,111,000 -1,111,000 -1,111,000 -1,111,000 -1,111,000               
          cash and cash equivalents at beginning of year
        		                                 
          cash and cash equivalents at end of year
        		                                 
          interest paid
        		           0 2,000 13,000 25,000 38,000 51,000 64,000 75,000 88,000 102,000 116,000 139,000 144,000 157,000 160,000 155,000 150,000 150,000 133,000 127,000 118,000  
          non-cash investing activity:
        		                                 
          proceeds from public offering of common stock, net of issuance costs, included in prepaid expenses, other current assets, and other assets
        		                                 
          lease liabilities
        		        -187,000 -304,000 -316,000                       
          deferred revenue
        		         -2,471,000 -142,000 -4,508,000 9,566,000 -1,408,000 -844,000 2,049,000 1,755,000 766,000 2,753,000 11,919,000 1,895,000 917,000 476,000 -1,097,000          
          amortization of operating lease right-of-use assets
        		          288,000 286,000 273,000 265,000 258,000                   
          amortization of debt issuance costs
        		               1,000 0 1,000 1,000 1,000 2,000    3,000         
          changes in operating assets and liabilities:
        		                                 
          proceeds from issuance of common and series x preferred pursuant to rights offering, net of issuance costs.
        		                                 
          net increase in cash, cash equivalents, and restricted cash
        		             -12,963,000 -24,303,000   4,310,000 5,840,000   -10,229,000 14,046,000           
          cash, cash equivalents, and restricted cash at beginning of year
        		                                 
          cash, cash equivalents, and restricted cash at end of year
        		                                 
          purchases of property and equipment included in accounts payable and accrued liabilities
        		              16,000                   
          proceeds from public offering of common stock, net of issuance costs, included in prepaid expenses and other current assets
        		           -2,000                      
          net decrease in cash, cash equivalents, and restricted cash
        		                          -17,155,000       
          cash, cash equivalents, and restricted cash at beginning of period
        		            0 0 62,273,000  0 0 42,949,000  0 0 60,268,000    74,562,000       
          cash, cash equivalents, and restricted cash at end of period
        		            28,071,000 -12,963,000 37,970,000  -12,794,000 4,310,000 48,789,000  -10,417,000 -10,229,000 74,314,000    57,407,000       
          change in fair value of contingent forward purchase obligations
        		                       0 0 -681,000 270,000 -4,075,000 -888,000     
          prepaid expenses and other current assets
        		                       -1,850,000 -490,000 -305,000 -301,000 1,441,000 -931,000 -155,000 -381,000 -416,000 430,000 
          other assets
        		                       801,000 -456,000   -1,210,000 128,000    0 
          proceeds from issuance of common stock pursuant to stock purchase agreement
        		                       0          
          deferred public offering costs
        		                                 
          operating lease right-of-use assets and liabilities
        		                72,000 -16,000 -17,000 -22,000 -12,000 -11,000 -12,000 -6,000 -7,000 -12,000 72,000       
          proceeds from issuance of common and series x preferred stock pursuant to rights offering, net of issuance costs
        		                                 
          amortization of discount or premium on short-term investments
        		                           -5,000 -17,000 2,000 -8,000 -39,000 -49,000 
          deferred rent
        		                           19,000 20,000 -9,000 -5,000 -5,000 -4,000 
          contingent forward purchase obligation offering costs
        		                           1,000 4,000     
          purchases of short-term investments
        		                           0 0    0 
          maturities of short-term investments
        		                           4,500,000 9,770,000 0 7,900,000 11,400,000 35,500,000 
          proceeds from registered direct offering, net of offering costs
        		                                 
          vesting of early exercised stock options
        		                           0 3,000 10,000 9,000 16,000 31,000 
          accounts receivable, prepaid expenses, other current assets, and other assets
        		                    -953,000 354,000 -1,328,000           
          proceeds from issuance of common and preferred stock pursuant to rights offering, net of issuance costs
        		                    0 0 29,186,000           
          proceeds from issuance of common stock, net of issuance costs
        		                    4,822,000 4,680,000 19,000           
          principal paid on term loan
        		                    -1,111,000             
          sale of shares pursuant to employee stock purchase plan
        		                    0             
          property and equipment included in accounts payable
        		                                 
          amortization of debt issue costs
        		                          2,000       
          proceeds from issuance of common stock, net of offering costs
        		                                 
          repurchase of unvested restricted stock
        		                             0 0 -79,000  
          property and equipment acquired but not yet paid
        		                           -3,000     -17,000 
          receivable for issuance of common stock, net of offering costs
        		                                 
          contingent forward purchase obligations offering costs
        		                                 
          proceeds from may 2018 registered direct offering, net of offering costs
        		                            -2,243,000     
          proceeds from issuance of common stock under equity sales agreement, net of issuance costs
        		                            0     
          offering costs incurred but not yet paid
        		                                 
          accrued compensation
        		                          -774,000 434,000 442,000 276,000 481,000 -1,129,000 688,000 
          non-cash investing and financing activities:
        		                                 
          proceeds from issuance of term loan, net of offering costs
        		                                 
          issuance of warrants to purchase common stock upon execution of term loan
        		                                 
          amortization of debt issuance costs and debt discount
        		                            9,000     
          proceeds from issuance of common stock pursuant to employee stock purchase plan
        		                                 
          net decrease in cash and cash equivalents
        		                             -23,736,000 -4,186,000 -3,169,000  
          debt issuance costs
        		                                 
          change in fair value of convertible notes payable
        		                                 
          purchase of in-process research and development
        		                                 
          proceeds form issuance of common stock, net of offering costs
        		                                 
          proceeds from issuance of series a convertible preferred stock, net of offering costs
        		                                 
          proceeds from issuance of series b convertible preferred stock, net of offering costs
        		                                 
          proceeds from issuance of convertible notes payable, net of offering costs
        		                                 
          deferred initial public offering costs
        		                                 
          conversion of series a convertible preferred stock to common stock upon initial public offering
        		                                 
          conversion of series b convertible preferred stock to common stock upon initial public offering
        		                                 
          conversion of convertible notes payable and accrued interest to series a convertible preferred shares
        		                                 
          proceeds from initial public offering, net of offering costs
        		                                 
          deferred initial public offering costs paid in 2014